22.02.2016 13:14:00
|
Recipharm AB: Invitation to Presentation of Recipharm’s Full Year Report for 2015 on the 24th February
Regulatory News:
Recipharm (STO: RECIB) will publish its Full Year report for January-December 2015 on 24 February at 07:45 am CET.
The company invites investors, analysts and media to a web conference (in English) on 24 February at 10:00 am CET, where CEO Thomas Eldered and CFO Björn Westberg will present and comment on the report as well as answer questions.
The report will be available on Recipharm’s website www.recipharm.com/investor-relations from 07:45 am CET the same day and the presentation from the webcast will be uploaded during the day on the 24 February.
To participate in the web conference, please use the below link:
http://edge.media-server.com/m/p/ezesfo38
Questions may be submitted by dialing below telephone numbers or by typing them in the Q&A box during the conference. If you don’t wish to ask questions by telephone you only need to participate through the link above.
From Sweden: + 46 8 505 56 453
From Denmark: + 45 35 44 55 74
From Finland: + 358 9 8171 0490
From Norway: + 47 235 00 251
From the UK: + 44 203 009 24 55
From Germany: +49 211 971 900 76
From Switzerland: +41 225 80 29 94
From France: + 33 170750706
From Spain: +34 911 140 089
From Portugal: +35 121 06 09 104
From the USA: +1 855 228 3719
Pin code for participants:
85232205#
For questions about participation in the event, please contact:
Linda Holmström, Brand & Communications Manager, + 46 8 602 45 13, linda.holmstrom@recipharm.com
Recipharm AB (publ)
Corporate identity number 556498-8425
Address Lagervägen 7, SE-136 50 Jordbro, Sweden, Telephone 46 8 602 52 00, Fax 46 8 81 87 03
www.recipharm.com
This information was brought to you by Cision http://news.cision.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20160222005724/en/

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Recipharm AB (B)mehr Nachrichten
Keine Nachrichten verfügbar. |